{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:16:13Z","timestamp":1722644173181},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Takayasu arteritis-induced renal arteritis (TARA), commonly seen in Takayasu arteritis (TA), has become one of the main causes of poor prognosis and early mortality in patients with TA. TARA progressing into Takayasu arteritis-induced renal artery stenosis (TARAS), could lead to severe complications including malignant hypertension, cardiac-cerebral vascular disease, and ischemic nephropathy. Since there existed no guidelines on treatments, this study aimed to review the comprehensive treatments for TARA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched systematically in databases including PubMed, Ovid-Medline, EMBASE, Web of Science, China National Knowledge Infrastructure, Wanfang, and SinoMed, from inception to May 2018. Literature selection, data extraction, and statistical analysis were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty-two literatures were recruited focusing on medical treatments (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a34) and surgical treatments (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a=\u200a48). We found that combined medical treatments of glucocorticoids and conventional synthetic disease-modifying anti-rheumatic drugs could reach high rates of remission in patients with TARA, and biological disease-modifying anti-rheumatic drugs were preferred for refractory patients. After remission induction, surgical treatment could help reconstruct renal artery and recover renal function partly. Percutaneous transluminal angioplasty was the first choice for patients with TARAS, while open surgery showed a good long-term survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with TARA should benefit both from medical treatments and from surgical treatments comprehensively and sequentially. Multidisciplinary team coordination is recommended especially in patients with severe complications.<\/jats:p><\/jats:sec>","DOI":"10.1097\/cm9.0000000000000704","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T22:21:36Z","timestamp":1584570096000},"page":"975-981","source":"Crossref","is-referenced-by-count":8,"title":["Advancements in medical and surgical treatments of Takayasu arteritis-induced renal arteritis: a systematic review"],"prefix":"10.1097","volume":"133","author":[{"given":"Xiao-Min","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Meng","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ying","sequence":"additional","affiliation":[{"name":"Fudan University Library, Shanghai 200032, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Di","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"R1-20230813","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrrheum.2010.82","article-title":"Takayasu arteritis-advances in diagnosis and management","volume":"6","author":"Mason","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20230813","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1161\/CIRCULATIONAHA.107.760686","article-title":"Aortitis","volume":"117","author":"Gornik","year":"2008","journal-title":"Circulation"},{"key":"R3-20230813","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF01744544","article-title":"Takayasu arteritis in Japan","volume":"7","author":"Koide","year":"1992","journal-title":"Heart Vessels Suppl"},{"key":"R4-20230813","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/1756-185X.12309","article-title":"Recent advances in Takayasu arteritis","volume":"17","author":"Terao","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"R5-20230813","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0167-5273(96)88777-8","article-title":"Current status of large and small vessel vasculitis in Japan","volume":"54","author":"Toshihiko","year":"1996","journal-title":"Int J Cardiol"},{"key":"R6-20230813","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/S0167-5273(96)02813-6","article-title":"Angiographic findings of Takayasu arteritis: new classification","volume":"54","author":"Hata","year":"1996","journal-title":"Int J Cardiol"},{"key":"R7-20230813","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.22404","article-title":"Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients","volume":"56","author":"Maksimowicz-Mckinnon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R8-20230813","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.kint.2017.06.027","article-title":"The renal artery is involved in Chinese Takayasu's arteritis patients","volume":"93","author":"Chen","year":"2018","journal-title":"Kidney Int"},{"key":"R9-20230813","first-page":"36","article-title":"Diagnostic value of captopril renography in identification of renal artery stenosis (in Chinese)","volume":"23","author":"Wei","year":"2008","journal-title":"Chin Circ J"},{"key":"R10-20230813","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10067-010-1496-1","article-title":"Takayasu's arteritis: clinical features and outcomes of 125 patients in China","volume":"29","author":"Cong","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R11-20230813","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajh.2010.174","article-title":"Renovascular hypertension and ischemic nephropathy","volume":"23","author":"Textor","year":"2010","journal-title":"Am J Hypertens"},{"key":"R12-20230813","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.CIR.80.3.429","article-title":"Natural history of aortoarteritis (Takayasu's disease)","volume":"80","author":"Subramanyan","year":"1989","journal-title":"Circulation"},{"key":"R13-20230813","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/01.CIR.90.4.1855","article-title":"Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors","volume":"90","author":"Ishikawa","year":"1994","journal-title":"Circulation"},{"key":"R14-20230813","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"R15-20230813","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.1780370420","article-title":"Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate","volume":"37","author":"Hoffman","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R16-20230813","first-page":"S27","article-title":"Response of Takayasu arteritis (TA) to prednisolone and methotrexate: an open label study","volume":"8","author":"Gokhale","year":"2013","journal-title":"Indian J Rheumatol"},{"key":"R17-20230813","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/03009742.2011.633553","article-title":"Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study","volume":"41","author":"de Souza","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R18-20230813","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rbr.2015.09.007","article-title":"Leflunomide in Takayasu arteritis - a long term observational study","volume":"56","author":"de Souza","year":"2016","journal-title":"Rev Bras Rheumatol"},{"key":"R19-20230813","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10067-007-0596-z","article-title":"Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis","volume":"26","author":"Shinjo","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R20-20230813","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10067-009-1333-6","article-title":"Mycophenolate mofetil in Takayasu's arteritis","volume":"29","author":"Goel","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R21-20230813","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.avsg.2007.03.021","article-title":"The management of Takayasu's arteritis: personal experience","volume":"21","author":"de Franciscis","year":"2007","journal-title":"Ann Vasc Surg"},{"key":"R22-20230813","first-page":"S43","article-title":"Cyclophosphamide for large-vessel vasculitis: assessment of response by PET\/CT","volume":"29","author":"Henes","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R23-20230813","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/RHU.0000000000000106","article-title":"Treatment of pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study","volume":"20","author":"Stern","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"R24-20230813","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s004670050526","article-title":"A review of Takayasu's arteritis in children in Gauteng, South Africa","volume":"12","author":"Hahn","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"R25-20230813","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00296-017-3847-6","article-title":"Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with Takayasu's arteritis","volume":"37","author":"Sun","year":"2017","journal-title":"Rheumatol Int"},{"key":"R26-20230813","first-page":"681","article-title":"Efficacy of anti-interleukin-6 receptor antibody (tocilizumab) in Colombian patients with Takayasu arteritis","volume":"71","author":"Canas","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R27-20230813","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.autrev.2013.06.019","article-title":"Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review","volume":"12","author":"Abisror","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R28-20230813","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/1756-185X.12220","article-title":"Rapid control of disease activity by tocilizumab in 10 \u2018difficult-to-treat\u2019 cases of Takayasu arteritis","volume":"16","author":"Goel","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"R29-20230813","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3899\/jrheum.130536","article-title":"Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center","volume":"40","author":"Tombetti","year":"2013","journal-title":"J Rheumatol"},{"key":"R30-20230813","first-page":"S79","article-title":"Tocilizumab in refractory aortitis: study on 16 patients and literature review","volume":"32","author":"Loricera","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R31-20230813","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","article-title":"Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomized, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)","volume":"77","author":"Nakaoka","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R32-20230813","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.114.014321","article-title":"Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients","volume":"132","author":"Mekinian","year":"2015","journal-title":"Circulation"},{"key":"R33-20230813","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/rheumatology\/ker380","article-title":"Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study","volume":"51","author":"Mekinian","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R34-20230813","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RHU.0000000000000098","article-title":"Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis","volume":"20","author":"Canas","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"R35-20230813","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/art.20300","article-title":"Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis","volume":"50","author":"Hoffman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R36-20230813","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/ard.2008.093260","article-title":"Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up","volume":"67","author":"Molloy","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R37-20230813","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/acr.21636","article-title":"Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term follow-up","volume":"64","author":"Schmidt","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R38-20230813","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8028-z","article-title":"Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?","volume":"34","author":"Galarza","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"R39-20230813","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/ard.2011.153007","article-title":"Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab","volume":"71","author":"Hoyer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R40-20230813","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10067-014-2506-5","article-title":"Two Takayasu arteritis patients successfully treated with rituximab","volume":"33","author":"Caltran","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R41-20230813","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.40037","article-title":"A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of takayasu arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R42-20230813","first-page":"27","article-title":"Experience and new progression of surgical treatment for aortoarteritis: an analysis of 236 patients","volume":"39","author":"Liu","year":"2004","journal-title":"Chin J Med"},{"key":"R43-20230813","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/jhh.2015.40","article-title":"Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China","volume":"30","author":"Peng","year":"2016","journal-title":"J Hum Hypertens"},{"key":"R44-20230813","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2015.12.006","article-title":"Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: two-year results","volume":"205","author":"Peng","year":"2016","journal-title":"Int J Cardiol"},{"key":"R45-20230813","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1161\/CIRCULATIONAHA.107.759589","article-title":"Overview of late outcome of medical and surgical treatment for Takayasu arteritis","volume":"118","author":"Ogino","year":"2008","journal-title":"Circulation"},{"key":"R46-20230813","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archsurg.2010.183","article-title":"Late outcomes of endovascular and open revascularization for nonatherosclerotic renal artery disease","volume":"145","author":"Ham","year":"2010","journal-title":"Arch Surg"},{"key":"R47-20230813","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0967-2109(98)00095-7","article-title":"Surgical treatment for aortic regurgitation caused by non-specific aortitis","volume":"7","author":"Ando","year":"1999","journal-title":"Cardiovasc Surg"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T12:03:05Z","timestamp":1722600185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000704","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"type":"print","value":"0366-6999"},{"type":"electronic","value":"2542-5641"}],"subject":[],"published":{"date-parts":[[2020,3,16]]}}}